DK2093217T3 - Fremgangsmåde til fremstilling af form X af aripiprazol - Google Patents
Fremgangsmåde til fremstilling af form X af aripiprazolInfo
- Publication number
- DK2093217T3 DK2093217T3 DK09160600.4T DK09160600T DK2093217T3 DK 2093217 T3 DK2093217 T3 DK 2093217T3 DK 09160600 T DK09160600 T DK 09160600T DK 2093217 T3 DK2093217 T3 DK 2093217T3
- Authority
- DK
- Denmark
- Prior art keywords
- aripiprazole
- preparing form
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05001638A EP1686117A1 (en) | 2005-01-27 | 2005-01-27 | Polymorph and solvates of aripiprazole |
EP06706450A EP1844016A1 (en) | 2005-01-27 | 2006-01-27 | Polymorph and solvates of aripiprazole |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2093217T3 true DK2093217T3 (da) | 2014-05-05 |
Family
ID=34933463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09160600.4T DK2093217T3 (da) | 2005-01-27 | 2006-01-27 | Fremgangsmåde til fremstilling af form X af aripiprazol |
Country Status (9)
Country | Link |
---|---|
US (1) | US8008490B2 (da) |
EP (1) | EP1686117A1 (da) |
JP (1) | JP5285914B2 (da) |
CN (1) | CN101370780B (da) |
AU (1) | AU2006208629B2 (da) |
CA (1) | CA2595334C (da) |
DK (1) | DK2093217T3 (da) |
SI (1) | SI2093217T1 (da) |
WO (1) | WO2006079548A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200529850A (en) * | 2003-12-16 | 2005-09-16 | Teva Pharma | Methods of preparing aripiprazole crystalline forms |
US7714129B2 (en) * | 2003-12-16 | 2010-05-11 | Teva Pharmaceutical Industries Ltd. | Methods of preparing anhydrous aripiprazole form II |
US7309830B2 (en) * | 2005-05-03 | 2007-12-18 | Toyota Motor Engineering & Manufacturing North America, Inc. | Nanostructured bulk thermoelectric material |
CA2600541C (en) † | 2005-03-17 | 2018-01-09 | Synthon B.V. | Process of making crystalline type ii aripiprazole |
WO2007004061A1 (en) * | 2005-04-15 | 2007-01-11 | Medichem, S.A. | Syntheses and preparations of polymorphs of crystalline aripiprazole |
PL1808165T3 (pl) * | 2006-01-05 | 2009-09-30 | Teva Pharma | Suche formulacje aripiprazolu |
WO2007081366A1 (en) * | 2006-01-05 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Wet granulation pharmaceutical compositions of aripiprazole |
EP2238976B1 (en) * | 2009-04-03 | 2012-06-27 | Hexal AG | Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof |
CN105085397B (zh) * | 2014-05-30 | 2018-02-09 | 上海特化医药科技有限公司 | 阿立哌唑半乙醇合物新晶型、其制备方法及用途 |
CN106474058B (zh) | 2015-08-31 | 2020-01-07 | 南京诺瑞特医药科技有限公司 | 具有延长的保质期的阿立哌唑可注射悬浮液制剂 |
CN108602774B (zh) * | 2016-02-19 | 2021-07-27 | 南京诺瑞特医药科技有限公司 | 阿立哌唑的新晶型 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4058935A (en) * | 1975-10-29 | 1977-11-22 | Vibrodyne, Inc. | Vibratory apparatus with electromagnet control system |
JPH0687124B2 (ja) * | 1987-02-26 | 1994-11-02 | アグフアーゲヴエルト・アクチエンゲゼルシヤフト | 写真記録材料 |
JP2608788B2 (ja) * | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神分裂病治療剤 |
US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
AR033485A1 (es) * | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
DE10158500A1 (de) | 2001-11-28 | 2003-06-12 | Basf Ag | Transparente Styrol-Butadien-Blockcopolymermischungen |
CA2428237C (en) * | 2003-05-08 | 2010-07-20 | Delmar Chemicals Inc. | Process for the preparation of carbostyril derivatives |
WO2005009990A1 (en) * | 2003-07-25 | 2005-02-03 | Hetero Drugs Limited | Aripiprazole crystalline forms |
TW200529850A (en) * | 2003-12-16 | 2005-09-16 | Teva Pharma | Methods of preparing aripiprazole crystalline forms |
WO2006030446A1 (en) | 2004-09-13 | 2006-03-23 | Matrix Laboratories Ltd | Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts |
CN101107242B (zh) * | 2005-01-27 | 2011-08-10 | 桑多斯股份公司 | 阿立哌唑的盐 |
-
2005
- 2005-01-27 EP EP05001638A patent/EP1686117A1/en not_active Withdrawn
-
2006
- 2006-01-27 AU AU2006208629A patent/AU2006208629B2/en not_active Ceased
- 2006-01-27 US US11/795,909 patent/US8008490B2/en not_active Expired - Fee Related
- 2006-01-27 CN CN2006800029249A patent/CN101370780B/zh not_active Expired - Fee Related
- 2006-01-27 DK DK09160600.4T patent/DK2093217T3/da active
- 2006-01-27 CA CA2595334A patent/CA2595334C/en not_active Expired - Fee Related
- 2006-01-27 SI SI200631777T patent/SI2093217T1/sl unknown
- 2006-01-27 WO PCT/EP2006/000725 patent/WO2006079548A1/en active Application Filing
- 2006-01-27 JP JP2007552585A patent/JP5285914B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1686117A1 (en) | 2006-08-02 |
CA2595334A1 (en) | 2006-08-03 |
WO2006079548A1 (en) | 2006-08-03 |
SI2093217T1 (sl) | 2014-06-30 |
JP5285914B2 (ja) | 2013-09-11 |
US20080132518A1 (en) | 2008-06-05 |
JP2008531477A (ja) | 2008-08-14 |
CN101370780B (zh) | 2012-05-16 |
US8008490B2 (en) | 2011-08-30 |
CN101370780A (zh) | 2009-02-18 |
AU2006208629A1 (en) | 2006-08-03 |
AU2006208629B2 (en) | 2010-02-18 |
CA2595334C (en) | 2016-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2093217T3 (da) | Fremgangsmåde til fremstilling af form X af aripiprazol | |
DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
DK2046767T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
DK1852430T3 (da) | Fremgangsmåde til fremstilling af proanthocyanidinoligomer | |
DK2044002T3 (da) | Fremgangsmåde til fremstilling af 3-substituerede 2-amino-5-halobenzamider | |
DK1981863T3 (da) | Fremgangsmåde til fremstilling af aminocrotonylaminosubtituerede quinazolinderivater | |
DK1896065T3 (da) | Fremgangsmåde til fremstilling af vacciner | |
DK1795576T3 (da) | Fremgangsmåde til fremstilling af carbonhydrider | |
DK1856024T4 (da) | Fremgangsmåde til fremstilling af substituerede biphenyler | |
DK1858342T3 (da) | Fremgangsmåde til fremstilling af ernæringssammensætninger | |
DK2423325T3 (da) | Fremgangsmåde til fremstilling af biblioteker af template-polynukleotider | |
DK2054711T3 (da) | Fremgangsmåde til fremstilling af mikroarrays | |
DK2215031T3 (da) | Fremgangsmåde til bearbejdning af pozzolaner | |
DK2073636T3 (da) | Fremgangsmåde til fremstilling af oxymorphon | |
DK2348064T3 (da) | Fremgangsmåde til fremstilling af polyalkylenglycolderivater | |
DK2213654T3 (da) | Fremgangsmåde til fremstilling af 2-amino-5-brombenzamid derivater | |
DK2029567T3 (da) | Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater | |
NO20076030L (no) | Fremgangsmåte for fremstilling av hydroklorsilaner | |
DK2061746T3 (da) | Fremgangsmåde til fremstilling af diestere | |
DK1480953T4 (da) | Fremgangsmåde til fremstilling af aripiprazol | |
DK1963251T3 (da) | Fremgangsmåde til fremstilling af aminer | |
DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin |